New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
09:05 EDTWMGI, CNMD, ARTC, SNNArthroCare deal favorable for Wright Medical, CONMED, says Summer Street
Summer Street believes the valuation multiple paid for ArthroCare (ARTC) by Smith & Nephew (SNN) is favorable for Wright Medical (WMGI) and CONMED (CNMD). The firm views the deal as low risk for Smith & Nephew and believes it will be accretive to the company's overall growth rate.
News For WMGI;CNMD;ARTC;SNN From The Last 14 Days
Check below for free stories on WMGI;CNMD;ARTC;SNN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 22, 2014
07:22 EDTSNNMedAssets to hold a summit
Subscribe for More Information
April 17, 2014
16:31 EDTSNNFDA alert on laparoscopic morcellation mixed for Hologic, says Piper Jaffray
Subscribe for More Information
15:51 EDTCNMDDealReporter sees potential interest in CONMED as likely limited, Bloomberg says
April 16, 2014
08:56 EDTCNMDCONMED could be worth $59 per share in buyout, says Needham
Subscribe for More Information
April 15, 2014
16:32 EDTCNMDCONMED exploring sale of company, Reuters reports
Subscribe for More Information
15:35 EDTCNMDCONMED moves higher following report of exploring sale
Subscribe for More Information
15:35 EDTCNMDCONMED asks financial advisers to explore sale of company, Reuters says
Subscribe for More Information
April 10, 2014
08:18 EDTWMGIWright Medical upgraded to Outperform from Neutral at RW Baird
As previously reported, Baird upgraded Wright Medical to Outperform from Neutral. The firm upgraded shares due to valuation, an improved position in both hammer toe and ankle replacement and expectations for accelerating organic growht. Price target is $$36.
06:04 EDTWMGIWright Medical upgraded to Outperform from Neutral at RW Baird
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use